Worksite wellness program for respiratory disease prevention in heavy-construction workers

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 3, 2011, Pages 274-281

  Hnizdo, Eva ^a   Berry, Angela ^b   Hakobyan, Artak ^c   Beeckman Wagner, Lu Ann ^a   Catlett, Larry ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b OccupationalMedical Consulting   (United States)

^c Systems Research Applications International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CLINICAL EVALUATION; CONSTRUCTION WORK; CONTROLLED STUDY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH PROGRAM; HUMAN; INDUSTRIAL WORKER; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH SERVICE; OCCUPATIONAL PHYSICIAN; OCCUPATIONAL SAFETY; PERIODIC MEDICAL EXAMINATION; PREVENTION STUDY; PROTECTIVE EQUIPMENT; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SMOKING CESSATION; SPIROMETRY; UNITED STATES; WEIGHT REDUCTION; WORK ENVIRONMENT; CROSS-SECTIONAL STUDY; HEALTH PROMOTION; INDUSTRY; LONGITUDINAL STUDY; MIDDLE AGED; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PROMOTION; HUMANS; INDUSTRY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY TRACT DISEASES; SPIROMETRY; UNITED STATES;

EID: 79953043087     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31820b0ab1     Document Type: Article

References (51)

1. Loeppke R, Taitel M, Richling D, et al. Health and productivity as a business strategy. J Occup Environ Med. 2007;49:712-721. (Pubitemid 47057650)
2. Loeppke R, Taitel M, Haufle V, Parry T, Kessler RC, Jinnett K. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med. 2009;51:411-428.
3. College ofOccupational and Environmental Medicine. Medical surveillance of workers exposed to crystalline silica. Position statement. Available at: http://www.acoem.org/guidelines.aspx?id=746. Accessed January 13, 2011.
4. National Institute for Occupational Safety and Health. Work Life. Available at: http://www.cdc.gov/niosh/worklife/. Accessed January 13, 2011.
5. Goetzel RZ, Ozminkowski RJ. The health and cost benefit ofworksite health-promotion programs. Annu Rev Public Health. 2008;29:303-323. (Pubitemid 351600411)
6. Darkow T, Chastek BJ, Shah H, Phillips AL. Health care cost among in-dividuals with chronic obstructive disease within several large, multi-state employers. J Occup Environ Med. 2008;50:1130-1138.
7. Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP. A retrospec-tive analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med. 2007;49: 22-30. (Pubitemid 46095587)
8. American Thoracic Society. Occupational contribution to the burden of airway disease. Am JRespir Crit Care Med. 2003;167:787-797.
9. Bakke B, Ulvestad B, Stewart P, Eduard W. Cumulative exposure to dust and gases as determinants oflung function decline in tunnel construction workers. Occup Environ Med. 2004;61:262-269. (Pubitemid 38339903)
10. Bergdahl IA, Toren K, Eriksson K, et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J. 2004;23: 402-406. (Pubitemid 38344376)
11. Mak GK, Gould MK, Kuschner WG. Occupational inhalant exposure and respiratory disorders among never-smokers referred to a hospital pulmonary function laboratory. Am J Med Sci. 2001;322:121-126. (Pubitemid 32847822)
12. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occu-pation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002;156: 738-746. (Pubitemid 35155180)
13. Trupin L, Earnest G, SanPedro M, et al. The occupational burden of chronic obstructive pulmonarydisease. Eur Respi J. 2003;22:462-469. (Pubitemid 37098927)
14. Harber P, Tashkin DP, Simmons M, Craford L, Hnizdo E, Connett J; for the Lung Health Study Group. Effect of occupational exposure on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:994-1000. (Pubitemid 350127843)
15. Weinmann S, Vollmer WM, Breen V, et al. COPD and occupational exposures: a case-control study. J Occup Environ Med. 2008;50:561-569. (Pubitemid 351677639)
16. Boggia B, Farinaro E, Grieco L, Lucariello A, Carbone U. Burden ofsmoking and occupational exposure on etiology of chronic obstructive pulmonary disease in workers in Southern Italy. J Occup Environ Med. 2008;50:366-370.
17. Blank PD, Iribarren C, Trupin L, et al. Occupational exposures and the risk ofCOPD: dustytradesrevisited. Thorax. 2009;64:6-12
18. Rodriguez E, Ferrer J, Marti S, Zock JP, Plana E, Morell F. Impact ofoccupa-tional exposure on severity ofCOPD. Chest. 2008;134:1237-1243.
19. Blanc PD, Eisner MD, Earnest G, et al. Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease. J Occup Environ Med. 2009;51:804-810.
20. Beeckman LA, Wang ML, Petsonk EL, Wagner GR. Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am JRespir Crit Care Med. 2001;163: 633-639. (Pubitemid 32230821)
21. Sin DD, Stafinski T, Ng YC, Bell NR, Jacob P. The impactof chronic obstruc-tive pulmonary disease on work loss in the United States. Am JRespir Crit Care Med. 2002;165:704-707. (Pubitemid 34194761)
22. Sircar K, Hnizdo E, Petsonk E, Attfield M. Decline in lung function and mor-tality: implication formedicalmonitoring. Occup Environ Med. 2007;64:461-466. (Pubitemid 47020286)
23. Wagner GR. Screeningand Surveillance of Workers Exposed to Mineral Dust Geneva, Switzerland: World Health Organization; 1996.
24. Hankinson JL, Wagner GR. Medical screening using periodic spirometry for detectionof chronic lungdisease. Occup Med State Art Rev. 1993;8:353-361.
25. Harber P, Lockey JE. Pulmonary function testing in pulmonary prevention. Occup Med State Art Rev. 1993;8:69-79
26. American College of Occupational and Environmental Medicine. Spirometry inthe occupational setting. J Occup Environ Med. 2000;42:228-245.
27. ACOEM Position Statement: Evaluating pulmonary function change over time in the occupational setting. Available at: http://www.acoem.org/guidelines.aspx? id=746. Accessed January 13, 2011.
28. U.S. Department of Labor Occupational Safety and health administra-tion.Screening and Surveillance: A Guide to OSHA Standards. Available at: http://wwwosha.gov/SLTC/medicalsurveilla-nce/index.html. Accessed Jan-uary 13, 2011.
29. Departmentof Health and Human Services (NIOSH). Specific medical testsor examinations published inthe literature for OSHA-regulated substances. Publication No. 2005-110. Available at: http://www.cdc.gov/niosh/docs/2005-110/ nmed0205.html. Accessed January 13, 2011.
30. NIOSH Criteria Documents. Criteria for a Recommended Standard: Occupa-tional Exposure toRespiratory Coal Mine Dust. Cincinnati, OH: Department ofHealth andHuman Services (NIOSH); 1995.
31. Skloot GS, Schechter CB, Herbert R, et al. Longitudinal assessment of spirometry in the World Trade Center medical monitoring program. Chest. 2009;135:492-498.
32. Lockey JE, Hilbert TJ, Levin LP, et al. Airway obstruction related to di-acetyl exposure at microwave popcorn production facilities. Eur Respir J. 2009;34:63-71.
33. Gulati M, Slade MD, Fiellin MG, Cullen MR. Healthcare for obstructive lung disease in an industrial spirometry surveillance program. J Occup Environ Med. 2009;51:336-342.
34. Cianbro. Wellness program news. Available at: http://www.cianbro.com/ HealthSafety/HealthWellness/tabid/383/Default.aspx. Accessed January 13, 2011.
35. Spirometry Longitudinal Data Analysis (SPIROLA) software. Available at: http://www.cdc.gov/niosh/topics/spirometry/spirola.html. Accessed January 13, 2011.
36. Hnizdo E, Yan T, Hakobyan A, et al. Spirometry Longitudinal Data Analysis software (SPIROLA) for analysis ofspirometry data in workplace prevention or COPD treatment Open Med Inform J. 2010;4:94-102.
37. Miller MR, Hankinson J, Brusasco V, et al. Standardization ofspirometry Standardization of lung function testing. Eur Respir J. 2005;26: 319-338.
38. NIOSH spirometry course manual. Available at: http://www.cdc.gov/niosh/ topics/spirometry/training.html. Accessed May 2010.
39. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968. (Pubitemid 41632054)
40. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159:179-187. (Pubitemid 29036522)
41. Hnizdo E, Glindmeyer HW, Petsonk EL. Workplace spirometry monitoring for respiratory disease prevention: a method review. Int J Tuberc Lung Dis. 2010;14:796-805.
42. Hnizdo E, Sircar K, Glindmeyer HW, Petsonk EL. Longitudinal limits of normal decline in lung function in an individual. J Occup Environ Med. 2006;48:625-634. (Pubitemid 43904254)
43. Hnizdo E, Yan T, Sircar K, Harber P, Fleming J, Glindmeyer HW. Limits oflongitudinal decline for the interpretation ofannual changes in FEV1 in individuals. Occup Environ Med. 2007;64:701-707. (Pubitemid 47488098)
44. Wang ML, Avashia BH, Petsonk LE. Interpreting periodic lung function tests in individuals. The relationship between 1-to 5-year and long-term FEV1 changes. Chest. 2006;130:493-499. (Pubitemid 44267018)
45. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Bust AS. Case definition for chronic obstructive pulmonary disease. COPD J Chronic Obstr Pulmon Dis. 2006;3:95-100. (Pubitemid 43739181)
46. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Continuous longitu-dinal regression equations for pulmonary function measures. Eur Respir J. 1992;5:452-462.
47. Celli BR, MacNee W, and committee members. Standards for the diagnosis and treatment ofpatients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946. (Pubitemid 38807371)
48. Pauwels RA, Buist SA, Calverley PMA, Jenkins CR, Hurd SS, onbehalf ofthe GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1256-1276. (Pubitemid 32378468)
49. de Marco R, Accordini S, Anto JM, et al. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European Community Respiratory Health Survey. Am J Respir Crit Care Med. 2009;180:956-963.
50. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645-1648. (Pubitemid 8124466)
51. Leone N, Courbon D, Thomas F, et al. Lung Function impairment and metabolic syndrome. Critical role of abdominal obesity Am J Respir Crit Care Med. 2009;179:509-516.